AB0751 JUVENILE UVEİTİS: THE 3RD LEVEL EXPERIENCE

Background: Uveitis is the inflammation of uveal components eye (iris, choroid and retina) third leading cause blindness in world. It less common children than adults. Young are usually diagnosed late, as they cannot express their complaints. Objectives: With this work; We aimed to contribute literature by determining underlying primary diagnosis evaluating treatment response patients who were followed up our clinic with a non-infectious uveitis, mostly juvenile idiopathic arthritis. Methods: 93 under 18 years age uveitis included study. The data scanned retrospectively. According last biomicroscopic examinations, classified remission, inactive period active disease. Clinical characteristics, laboratory findings, family history, drugs used during disease duration examined. Results: male female ratio was 1,06 (48/45). mean at childhood found be 10±4.02. 49 Patients (52.6%) 33 (33.5%)with arthritis, 11 (11.7%) Behçet’s, 2 (2.2%) FMF. Juvenile arthritis most systemic patient group. rheumatological 10.1±5.32. ANA test positive 30 (32.2%) patients. 23 (69.7%) oligoartricular type. Anterior present 37 (39.8%) cases. Of 24 (25.8%) intermediate, (11.8%) posterior, 21 (22.6%) panuveitis. Anti-TNFα agents administered unresponsiveness immunosuppressive therapy high risk vision loss. Most anti-TNFα infliximab adalimumab. Glaucoma, cataract, posterior synechiae complications follow-up. Conclusion: that noninfectious In involvement anterior segment, it thought location could useful important ensure regular examination rheumatologic symptoms. Disclosure Interests: None declared